Zeng XY - Search Results

1

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients.

Li JM, Wang L, Shen Y, Xia ZG, Chen Y, Chen QS, Chen Y, Zeng XY, You JH, Qian Y, Shen ZX. Li JM, et al. Among authors: zeng xy. Ann Hematol. 2007 Sep;86(9):639-45. doi: 10.1007/s00277-007-0320-8. Epub 2007 Jun 16. Ann Hematol. 2007. PMID: 17572895 Clinical Trial.

2

The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution.

Zhao WL, Xu L, Wu W, Yan H, Tang W, Hu J, Chen Y, Li JM, Zeng XY, Xiong SM, Shen ZX, Chen Z, Wang ZY, Chen SJ. Zhao WL, et al. Among authors: zeng xy. Hematol J. 2002;3(3):137-44. doi: 10.1038/sj.thj.6200173. Hematol J. 2002. PMID: 12111649

3

Ramosetron for the management of chemotherapy-induced gastrointestinal events in patients with hematological malignancies.

Zeng XY, Wang AH, Liu YF, Chen Y, Shen Y, Shen ZX. Zeng XY, et al. Methods Find Exp Clin Pharmacol. 2001 May;23(4):191-5. doi: 10.1358/mf.2001.23.4.634643. Methods Find Exp Clin Pharmacol. 2001. PMID: 11676227 Free article. Clinical Trial.

4

[Epidemiology and drug resistance of the pathogenic microbes in the complicated infection of hematological malignancies].

Shen Y, Shen J, Chen Y, Zeng XY, Li JM, Ni YX, Shen ZX. Shen Y, et al. Among authors: zeng xy. Zhonghua Xue Ye Xue Za Zhi. 2004 Jun;25(6):328-32. Zhonghua Xue Ye Xue Za Zhi. 2004. PMID: 15308008 Chinese.

5

Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage.

Shen Y, Shen ZX, Yan H, Chen J, Zeng XY, Li JM, Li XS, Wu W, Xiong SM, Zhao WL, Tang W, Wu F, Liu YF, Niu C, Wang ZY, Chen SJ, Chen Z. Shen Y, et al. Among authors: zeng xy. Leukemia. 2001 May;15(5):735-41. doi: 10.1038/sj.leu.2402106. Leukemia. 2001. PMID: 11368433

6

[Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].

Liu Y, Ke XY, Ma J, Shen ZX, Zhang XH, Du X, Zhao YM, Lv JQ, Zhan ZM, Zeng XY, Xu XH, Lu ZS. Liu Y, et al. Among authors: zeng xy. Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):706-8. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17274381 Clinical Trial. Chinese.

7

[Multi-institutional randomized controlled clinical trial on China made 4-demethoxydaunokrubicin (IDA) in the treatment of acute leukemia].

Liu Y, Ke XY, Ma J, Shen ZX, Zhang XH, Du X, Zhao YM, Lü JQ, Zhan ZM, Zeng XY, Xu XH, Lu ZS. Liu Y, et al. Among authors: zeng xy. Zhonghua Zhong Liu Za Zhi. 2005 Dec;27(12):750-2. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16483490 Clinical Trial. Chinese.

8

Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients.

Niu C, Yan H, Yu T, Sun HP, Liu JX, Li XS, Wu W, Zhang FQ, Chen Y, Zhou L, Li JM, Zeng XY, Yang RR, Yuan MM, Ren MY, Gu FY, Cao Q, Gu BW, Su XY, Chen GQ, Xiong SM, Zhang TD, Waxman S, Wang ZY, Chen Z, Hu J, Shen ZX, Chen SJ. Niu C, et al. Among authors: zeng xy. Blood. 1999 Nov 15;94(10):3315-24. Blood. 1999. PMID: 10552940 Free article. Clinical Trial.

9

[Analysis of the efficacy of adjusting the dose of imatinib with therapeutic drug monitoring in adjuvant treatment after complete resection of gastrointestinal stromal tumors].

Chen ZL, Tian HK, Ding JN, Li ZY, Mao G, Du YY, Shen Q, Zhou H, Han Y, Zeng XY, Tao KX, Zhang P. Chen ZL, et al. Among authors: zeng xy. Zhonghua Wei Chang Wai Ke Za Zhi. 2024 Nov 25;27(11):1148-1154. doi: 10.3760/cma.j.cn441530-20240807-00273. Zhonghua Wei Chang Wai Ke Za Zhi. 2024. PMID: 39572180 Chinese.

10

[Reflections on critical care ultrasound training: clinical analysis, protocol, view, approach and practice-workflow (CPVAP) modular training and base training model].

Zeng XY, He W, Qin Y, Wang XT, Chao YG, Kang Y, Yin MG. Zeng XY, et al. Zhonghua Nei Ke Za Zhi. 2024 Nov 1;63(11):1052-1058. doi: 10.3760/cma.j.cn112138-20240613-00382. Zhonghua Nei Ke Za Zhi. 2024. PMID: 39482069 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

368 results

Search Page

Filters